techUK has praised the announcement of new funding for a number of areas of health technology. The funding follows recommendations from the Accelerated Access Review published last year. Four separate funding streams have been announced:
• £39 million of funding available to the Academic Health Science Networks (ASHNs), enabling them to locally assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients according to the local need.
• A £35 million Digital Health Technology Catalyst for innovators – this will match fund the development of digital technologies for use by patients and the NHS.
• Up to £6 million over the next three years to support SMEs with innovative medicines and devices to get the evidence they need by testing in the real world, building on existing opportunities such as the Early Access to Medicine Scheme (EAMS).
• A £6 million Pathway Transformation Fund which will help NHS organisations integrate new technologies into everyday practices - this will help overcome more practical obstacles such as training staff on how to use new equipment.
Commenting, Ben Moody, Head of Health and Social Care at techUK said:
“Having been involved in the Accelerated Access Review from its early days, we are pleased to see key recommendations being put into place. The funding will help to embolden AHSNs and ultimately get patients the technology that they need.
“The UK is a world leader in health tech but we must not be complacent. The Digital Health Technology Catalyst will be a great boost for innovators in the sector. The announcement also recognises that the resources needed to generate evidence to show that a technology is worth reimbursing can be prohibitively difficult for SMEs - so the fund to support evidence generation for innovative devices is particularly welcome.”